References
- Baas P, Belderbos J SA, van den Heuvel M (2011). Chemoradiation therapy in n on small cell lung cancer. Curr Opin Oncol, 23, 140-9. https://doi.org/10.1097/CCO.0b013e328341eed6
- Blattman JN, Greenberg PD (2004). Cancer immunotherapy: a treatment for the masses. Science, 305, 200-5. https://doi.org/10.1126/science.1100369
- Bordon E, Henriquez-Hernandez LA, Lara PC (2011). Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and Natural Killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients. Int J Radiat Biol, 87, 424-31. https://doi.org/10.3109/09553002.2010.537433
- Das S, Karim S, Datta Ray C (2007). Peripheral blood lymphocyte subpopulations in patients with cervical cancer. Int J Gynaecol Obstet, 98, 143-6. https://doi.org/10.1016/j.ijgo.2007.04.011
- Holtl L, Rieser C, Papesh C, et al (1999). Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendntic cell. J Urol, 161, 777-82. https://doi.org/10.1016/S0022-5347(01)61767-1
- Hongeng S, Petvises S, Worapongpaiboon S, et al (2003). Generation of CD3+CD56+ cytokine induced killer cells and their invitro cytotoxicity against pediatric cancer cells. Int J Hematol, 77, 175-9. https://doi.org/10.1007/BF02983217
- Hsu HS, Huang PI, Chang YL, et al (2011). Cucurbitacin i inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer, 117, 2970-85. https://doi.org/10.1002/cncr.25869
- Kim YJ, Lim J, Kang JS, et al (2010). Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Arch Pharm Res, 33, 1789-95. https://doi.org/10.1007/s12272-010-1111-7
- Kuss I, Hathway B, Ferris RL, et al (2004). Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res, 10, 3755-62. https://doi.org/10.1158/1078-0432.CCR-04-0054
- Levina V, Marrangoni A, Wan g T, et al (2010). Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res, 70, 338-46. https://doi.org/10.1158/0008-5472.CAN-09-1102
- Li R, Wang C, Liu L, et al (2012). Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study. Cancer Immunol Immunother, 61, 2125-33. https://doi.org/10.1007/s00262-012-1260-2
- Mendez R, Ruiz-Cabello F, Rodriguez T, et al(2007). Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherap. Cancer Immunol Immunother, 56, 88-94. https://doi.org/10.1007/s00262-006-0166-2
- Shepherd FA, Douillard JY and Blumenschein GR Jr (2011). Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome. J Thorac Oncol, 6, 1763-73. https://doi.org/10.1097/JTO.0b013e31822e28fc
- Shi M, Zhang B, Tang ZR, et al (2004). Autologous cytokine induced killer(CIK)cell therapy in clinical trial phaseⅠissafe in patients with primary hepatocellular carcinoma. World J Gastroenterol, 10, 1146-51.
- Sievers E, Albers P, Schmidt-Wolf IG , et al (2004). Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma. J Urol, 171, 114-9. https://doi.org/10.1097/01.ju.0000094803.60928.d7
- Urbanska K, Lanitis E, Poussin M, et al (2012). A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor. Cancer Res, 72 ,1844-52. https://doi.org/10.1158/0008-5472.CAN-11-3890
- Wang H, Zhou FJ, Wang QJ (2006). Efficacy of autologous renal tumor cell lysate- loaded dendritic cell vaccine in combination with cytokine- induced killer cells on advanced renal cell carcinoma- - a report of ten cases. Ai Zheng, 25, 625-30.
- Wongkajornsilp A, Somchitprasert T, Butraporn R, et al (2009). Human cytokine- induced killer cells specifically infiltrated and etarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice. Cancer Invest, 27, 140-8. https://doi.org/10.1080/07357900802189832
- Wu F, Wang ZB, Lu P, et al (2004). Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol, 30, 1217-22. https://doi.org/10.1016/j.ultrasmedbio.2004.08.003
- Xu Y, Liu LJ, Gao JM, et al (2010). Specific Anti- tumor Biological Activity of DCIK Cells. China Modern Doctor, 27, 360-2
- Zhang H, Zhao Q, Zuo LF, et al (2007). The functional mechanism of CIK cell on ovarian carcinoma cell lines SKOV3/CDDP. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 23, 1167-9.
Cited by
- Induction of Indoleamine 2,3-dioxygenase (IDO) Enzymatic Activity Contributes to Interferon-Gamma Induced Apoptosis and Death Receptor 5 Expression in Human Non-small Cell Lung Cancer Cells vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7995
- T-cell-associated cellular immunotherapy for lung cancer vol.141, pp.7, 2015, https://doi.org/10.1007/s00432-014-1867-0
- Advances in Immune Therapy for Non Small Cell Lung Cancer vol.06, pp.01, 2016, https://doi.org/10.12677/MD.2016.61004
- Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application vol.13, pp.6, 2017, https://doi.org/10.1080/21645515.2017.1285987
- Effect of cytokine-induced killer cells on immune function in patients with lung cancer vol.11, pp.4, 2016, https://doi.org/10.3892/ol.2016.4284